Atlas Trials

[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer

Clinical trial NCT06502691 · RECRUITING

Trial details

NCT number
NCT06502691
Sponsor
University of Washington
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast Carcinoma
Start date
2026-02-26
Primary completion
2027-12-31
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.